Home > Financial Ratios > SOLARA ACTIVE PHARMA SCIENCES

SOLARA ACTIVE PHARMA SCIENCES
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for SOLARA ACTIVE PHARMA SCIENCES
Please provide your vote to see the results

SOLARA ACTIVE PHARMA SCIENCES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 338.95-157.4156.45-75.8944.49

What is the latest Core EBITDA Growth ratio of SOLARA ACTIVE PHARMA SCIENCES ?

The latest Core EBITDA Growth ratio of SOLARA ACTIVE PHARMA SCIENCES is 338.95 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar2025338.95
Mar2024-157.41
Mar202356.45
Mar2022-75.89
Mar202144.49

How is Core EBITDA Growth of SOLARA ACTIVE PHARMA SCIENCES Trending?

Years Core EBITDA Growth % Change
Mar2025 338.95
Positive
Mar2024 -157.41
Negative
Mar2023 56.45
Positive
Mar2022 -75.89
Negative
Mar2021 44.49 -

Other Financial Ratios of SOLARA ACTIVE PHARMA SCIENCES


Compare Core EBITDA Growth ratio of peers of SOLARA ACTIVE PHARMA SCIENCES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SOLARA ACTIVE PHARMA SCIENCES ₹2,188.8 Cr -2.6% -5.1% -9.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹437,855.0 Cr 2.4% 7.1% 14.6% Stock Analytics
DIVIS LABORATORIES ₹168,550.0 Cr -0.2% 3.8% 15.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹149,906.0 Cr 1.8% 10.9% 48.4% Stock Analytics
DR REDDYS LABORATORIES ₹110,632.0 Cr 1% 4% 16.6% Stock Analytics
CIPLA ₹107,427.0 Cr 0.3% -0.9% -6% Stock Analytics


SOLARA ACTIVE PHARMA SCIENCES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SOLARA ACTIVE PHARMA SCIENCES

-2.6%

-5.1%

-9.4%

SENSEX

-2.9%

-8%

5.3%


You may also like the below Video Courses